Poor Response to Alirocumab in a Patient With Homozygous Familial Hypercholesterolemia

Am J Ther. 2019 Nov/Dec;26(6):e743-e745. doi: 10.1097/MJT.0000000000000898.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Cholesterol, LDL / blood
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy*
  • PCSK9 Inhibitors
  • Receptors, LDL / physiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Cholesterol, LDL
  • PCSK9 Inhibitors
  • Receptors, LDL
  • alirocumab